Septin 9 has also been shown to be in a frequently deleted region in breast and ovarian cancers in loss of heterozygosity (LOH) studies, a finding that further implicates the gene as a possible tumor suppressor [31]. This evidence concerns the gene SEPTIN9 and ovarian carcinoma.